{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:40:36Z","timestamp":1793788836938,"version":"4.6.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSS Academy of Higher Education and Research, Mysore","id":[{"id":"https:\/\/ror.org\/013x70191","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47049-w","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:57:57Z","timestamp":1783537077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decoding cytokine interactions for psoriasis therapy through computational repurposing of antihypertensive drugs"],"prefix":"10.1038","volume":"16","author":[{"given":"M. R. Sai","family":"Chakith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Pradeep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjith","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pruthvish","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Yellappa","family":"Kolachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Dharmashekara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Chaithra","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva Prasad","family":"Kollur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasim Sakran","family":"Abass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Stupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Satish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Shivamallu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Silina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"47049_CR1","doi-asserted-by":"publisher","first-page":"e19325","DOI":"10.7717\/peerj.19325","volume":"13","author":"MRS Chakith","year":"2025","unstructured":"Chakith, M. R. S. et al. Advancements in understanding and treating psoriasis: a comprehensive review of pathophysiology, diagnosis, and therapeutic approaches. PeerJ 13, e19325 (2025).","journal-title":"PeerJ"},{"key":"47049_CR2","doi-asserted-by":"publisher","first-page":"13313","DOI":"10.3390\/ijms241713313","volume":"24","author":"HJ Lee","year":"2023","unstructured":"Lee, H. J. & Kim, M. Challenges and future trends in the treatment of psoriasis. Int. J. Mol. Sci. 24, 13313 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"47049_CR3","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/ijms18102211","volume":"18","author":"SC Hu","year":"2017","unstructured":"Hu, S. C. & Lan, C. E. Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment. Int. J. Mol. Sci. 18, 2211 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"47049_CR4","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.3390\/ijms20143458","volume":"20","author":"IVG Silva","year":"2019","unstructured":"Silva, I. V. G., de Figueiredo, R. C. & Rios, D. R. A. Effect of different classes of antihypertensive drugs on endothelial function and inflammation. Int. J. Mol. Sci. 20, 3458 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"47049_CR5","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.3390\/ijms26115082","volume":"26","author":"JY Ahn","year":"2025","unstructured":"Ahn, J. Y. et al. Sinhyotaklisan as a potential therapeutic for psoriasis: network pharmacology and experimental validation. Int. J. Mol. Sci. 26, 5082 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"47049_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40744-014-0005-4","volume":"1","author":"PJ Mease","year":"2014","unstructured":"Mease, P. J. Apremilast: a phosphodiesterase 4 inhibitor for the treatment of psoriatic arthritis. Rheumatol. Ther. 1, 1\u201320 (2014).","journal-title":"Rheumatol. Ther."},{"key":"47049_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12906-021-03359-2","volume":"21","author":"A Ibezim","year":"2021","unstructured":"Ibezim, A., Onah, E., Dim, E. N. & Ntie-Kang, F. A computational multi-targeting approach for drug repositioning for psoriasis treatment. BMC Complement. Med. Ther. 21, 193 (2021).","journal-title":"BMC Complement. Med. Ther."},{"key":"47049_CR8","doi-asserted-by":"publisher","first-page":"1451679","DOI":"10.3389\/fgene.2024.1451679","volume":"15","author":"C Antonatos","year":"2024","unstructured":"Antonatos, C. et al. A polygenic risk score model for psoriasis based on the protein interactions of psoriasis susceptibility loci. Front. Genet. 15, 1451679 (2024).","journal-title":"Front. Genet."},{"issue":"Suppl. 4","key":"47049_CR9","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin, C. H. et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8 (Suppl. 4), S11 (2014).","journal-title":"BMC Syst. Biol."},{"key":"47049_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","volume":"9","author":"E Fitch","year":"2007","unstructured":"Fitch, E., Harper, E., Skorcheva, I., Kurtz, S. E. & Blauvelt, A. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr. Rheumatol. Rep. 9, 461\u2013467 (2007).","journal-title":"Curr. Rheumatol. Rep."},{"key":"47049_CR11","doi-asserted-by":"crossref","unstructured":"Kuwabara, T., Ishikawa, F., Kondo, M. & Kakiuchi, T. The role of IL-17 and related cytokines in inflammatory autoimmune diseases. Mediators Inflamm. 3908061 (2017).","DOI":"10.1155\/2017\/3908061"},{"key":"47049_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1089\/scd.2022.0004","volume":"31","author":"M Espinosa Gonzalez","year":"2022","unstructured":"Espinosa Gonzalez, M., Volk-Draper, L., Bhattarai, N., Wilber, A. & Ran, S. Th2 cytokines IL-4, IL-13, and IL-10 promote differentiation of pro-lymphatic progenitors derived from bone marrow myeloid precursors. Stem Cells Dev. 31, 322\u2013333 (2022).","journal-title":"Stem Cells Dev."},{"key":"47049_CR13","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.4110\/in.2023.23.e41","volume":"23","author":"P Topchyan","year":"2023","unstructured":"Topchyan, P., Lin, S. & Cui, W. The role of CD4 T cell help in CD8 T cell differentiation and function during chronic infection and cancer. Immune Netw. 23, e41 (2023).","journal-title":"Immune Netw."},{"key":"47049_CR14","doi-asserted-by":"publisher","first-page":"1492012","DOI":"10.3389\/fimmu.2025.1492012","volume":"16","author":"Z Wang","year":"2025","unstructured":"Wang, Z. & Luo, F. Integrated analysis of exosome-related genes and their role in psoriasis pathogenesis. Front. Immunol. 16, 1492012 (2025).","journal-title":"Front. Immunol."},{"key":"47049_CR15","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3390\/ijms23031772","volume":"23","author":"P Bryniarski","year":"2022","unstructured":"Bryniarski, P., Nazimek, K. & Marcinkiewicz, J. Immunomodulatory activity of the most commonly used antihypertensive drugs\u2014angiotensin converting enzyme inhibitors and angiotensin II receptor blockers. Int. J. Mol. Sci. 23, 1772 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"47049_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","volume":"66","author":"I Sieminska","year":"2024","unstructured":"Sieminska, I., Pieniawska, M. & Grzywa, T. M. The immunology of psoriasis\u2014current concepts in pathogenesis. Clin. Rev. Allergy Immunol. 66, 164\u2013191 (2024).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"47049_CR17","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/cimb44050127","volume":"44","author":"L \u021aiburc\u0103","year":"2022","unstructured":"\u021aiburc\u0103, L. et al. The treatment with interleukin 17 inhibitors and immune-mediated inflammatory diseases. Curr. Issues Mol. Biol. 44, 1851\u20131866 (2022).","journal-title":"Curr. Issues Mol. Biol."},{"key":"47049_CR18","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.3390\/ijms24032213","volume":"24","author":"RNL Lamptey","year":"2023","unstructured":"Lamptey, R. N. L., Sun, C., Layek, B. & Singh, J. Neurogenic hypertension, the blood-brain barrier, and the potential role of targeted nanotherapeutics. Int. J. Mol. Sci. 24, 2213 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"47049_CR19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.2174\/1381612820666141024151119","volume":"21","author":"A Zisaki","year":"2015","unstructured":"Zisaki, A., Miskovic, L. & Hatzimanikatis, V. Antihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approaches. Curr. Pharm. Des. 21, 806\u2013822 (2015).","journal-title":"Curr. Pharm. Des."},{"key":"47049_CR20","doi-asserted-by":"publisher","first-page":"16562","DOI":"10.1038\/s41598-024-67594-6","volume":"14","author":"X Lv","year":"2024","unstructured":"Lv, X., Wang, J. & Yuan, Y. In silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy. Sci. Rep. 14, 16562 (2024).","journal-title":"Sci. Rep."},{"key":"47049_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s40203-025-00386-6","volume":"13","author":"DR Martin","year":"2025","unstructured":"Martin, D. R., Ajmal, A., Meyer, M. & Madiehe, A. M. In silico identification of phytoconstituents from Capparis sepiaria as interleukin-1 inhibitors for rheumatoid arthritis: molecular docking, ADMET profiling, and molecular dynamics simulation. Silico Pharmacol. 13, 106 (2025).","journal-title":"Silico Pharmacol."},{"key":"47049_CR22","doi-asserted-by":"publisher","first-page":"107602","DOI":"10.1016\/j.bioorg.2024.107602","volume":"150","author":"V Apostolopoulos","year":"2024","unstructured":"Apostolopoulos, V. et al. Density functional theory and enzyme studies support interactions between angiotensin receptor blockers and angiotensin converting enzyme-2: relevance to coronavirus 2019. Bioorg. Chem. 150, 107602 (2024).","journal-title":"Bioorg. Chem."},{"key":"47049_CR23","first-page":"495","volume":"40","author":"T Zerilli","year":"2015","unstructured":"Zerilli, T., Ocheretyaner, E. & Apremilast Otezla): a new oral treatment for adults with psoriasis and psoriatic arthritis. P T. 40, 495\u2013500 (2015).","journal-title":"P T"},{"key":"47049_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/ph18040559","volume":"18","author":"N Alotaiq","year":"2025","unstructured":"Alotaiq, N. & Dermawan, D. Computational investigation of montelukast and its structural derivatives for binding affinity to dopaminergic and serotonergic receptors: insights from a comprehensive molecular simulation. Pharmaceuticals 18, 559 (2025).","journal-title":"Pharmaceuticals"},{"key":"47049_CR25","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1021\/acs.jcim.0c00057","volume":"60","author":"H Guterres","year":"2020","unstructured":"Guterres, H. & Im, W. Improving protein-ligand docking results with high-throughput molecular dynamics simulations. J. Chem. Inf. Model. 60, 2189\u20132198 (2020).","journal-title":"J. Chem. Inf. Model."},{"key":"47049_CR26","doi-asserted-by":"publisher","first-page":"e13301","DOI":"10.1111\/srt.13301","volume":"29","author":"F Zhou","year":"2023","unstructured":"Zhou, F., Yao, H., Ma, Z. & Hu, X. Investigating small molecule compounds targeting psoriasis based on cMAP database and molecular dynamics simulation. Skin. Res. Technol. 29, e13301 (2023).","journal-title":"Skin. Res. Technol."},{"key":"47049_CR27","first-page":"1","volume":"10","author":"TP Afra","year":"2019","unstructured":"Afra, T. P., Razmi, T. M. & Dogra, S. Apremilast in psoriasis and beyond: big hopes on a small molecule. Indian Dermatol. Online J. 10, 1\u201312 (2019).","journal-title":"Indian Dermatol. Online J."},{"key":"47049_CR28","doi-asserted-by":"publisher","first-page":"22103","DOI":"10.1038\/s41598-024-73746-5","volume":"14","author":"M Farahani","year":"2024","unstructured":"Farahani, M. et al. Integrating protein interaction and pathway crosstalk network reveals a promising therapeutic approach for psoriasis through apoptosis induction. Sci. Rep. 14, 22103 (2024).","journal-title":"Sci. Rep."},{"key":"47049_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40256-021-00510-9","volume":"22","author":"U Ojha","year":"2022","unstructured":"Ojha, U. et al. Current and emerging classes of pharmacological agents for the management of hypertension. Am. J. Cardiovasc. Drugs. 22, 271\u2013285 (2022).","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"47049_CR30","unstructured":"Maestro, S. Maestro (Schr\u00f6dinger, 2022)."},{"key":"47049_CR31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fchem.2020.00726","volume":"8","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. Computational approaches in preclinical studies on drug discovery and development. Front. Chem. 8, 726 (2020).","journal-title":"Front. Chem."},{"key":"47049_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00894-021-04987-8","volume":"27","author":"V Yele","year":"2021","unstructured":"Yele, V., Sigalapalli, D. K., Jupudi, S. & Mohammed, A. A. DFT calculation, molecular docking, and molecular dynamics simulation study on substituted phenylacetamide and benzohydrazide derivatives. J. Mol. Model. 27, 359 (2021).","journal-title":"J. Mol. Model."},{"key":"47049_CR33","doi-asserted-by":"crossref","unstructured":"Parr, R. G. & Yang, W. Density-functional theory of atoms and molecules (Oxford Academic, 1995).","DOI":"10.1093\/oso\/9780195092769.001.0001"},{"key":"47049_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/biomedicines13010195","volume":"13","author":"C Twala","year":"2025","unstructured":"Twala, C., Malindisa, S., Munnik, C., Sooklal, S. & Ntwasa, M. Ezetimibe anticancer activity via the p53\/Mdm2 pathway. Biomedicines 13, 195 (2025).","journal-title":"Biomedicines"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47049-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47049-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47049-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:06:38Z","timestamp":1791417998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47049-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47049"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47049-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31447"}}